Establishing Clonal Cell Lines with Endothelial-Like Potential from CD9hi, SSEA-1− Cells in Embryonic Stem Cell-Derived Embryoid Bodies

Abstract

BackgroundDifferentiation of embryonic stem cells (ESCs) into specific cell types with minimal risk of teratoma formation could be efficiently directed by first reducing the differentiation potential of ESCs through the generation of clonal, self-renewing lineage-restricted stem cell lines. Efforts to isolate these stem cells are, however, mired in an impasse where the lack of purified lineage-restricted stem cells has hindered the identification of defining markers for these rare stem cells and, in turn, their isolation.Methodology/Principal FindingsWe describe here a method for the isolation of clonal lineage-restricted cell lines with endothelial potential from ESCs through a combination of empirical and rational evidence-based methods. Using an empirical protocol that we have previously developed to generate embryo-derived RoSH lines with endothelial potential, we first generated E-RoSH lines from mouse ESC-derived embryoid bodies (EBs). Despite originating from different mouse strains, RoSH and E- RoSH lines have similar gene expression profiles (r2 = 0.93) while that between E-RoSH and ESCs was 0.83. In silico gene expression analysis predicted that like RoSH cells, E-RoSH cells have an increased propensity to differentiate into vasculature. Unlike their parental ESCs, E-RoSH cells did not form teratomas and differentiate efficiently into endothelial-like cells in vivo and in vitro. Gene expression and FACS analysis revealed that RoSH and E-RoSH cells are CD9hi, SSEA-1− while ESCs are CD9lo, SSEA-1+. Isolation of CD9hi, SSEA-1− cells that constituted 1%–10% of EB-derived cultures generated an E-RoSH-like culture with an identical E-RoSH-like gene expression profile (r2 = 0.95) and a propensity to differentiate into endothelial-like cells.ConclusionsBy combining empirical and rational evidence-based methods, we identified definitive selectable surface antigens for the isolation and propagation of lineage-restricted stem cells with endothelial-like potential from mouse ESCs.

The Human Nose Harbors a Niche of Olfactory Ectomesenchymal Stem Cells Displaying Neurogenic and Osteogenic Properties

“…Alternative names are mentioned in parentheses. [44][45][46][47]. CD200 is a membrane glycoprotein that co-stimulates T-cell proliferation and may regulate myeloid cell activity.…”

The Stem Cell Identity of Testicular Cancer

“…Over-expression of CD9 has been observed in cancers of the pancreas [93], bladder [94] and ovary [95] and now germ cell tumors [83]. Expression of CD9 has not been examined in hESCs; however, in the mouse, it appears to segregate with the differentiating ESC population and not self-renewing pluripotent mouse ESCs [96]. CD9 knockout mice have defects in fertility; however, the phenotype is associated with sperm-egg binding deficits rather than germ cell differentiation [97].…”

Embryonic Stem Cells for Therapies – Challenges and Possibilities

“…However, the cell populations generated using this protocol have low insulin content. Using an approach that combines elements from this protocol and that used in neural differentiation, we first derived highly expansible E-RoSH cell lines with meso-endoderm potential from spontaneously differentiating EBs (Lian et al, 2006;Yin et al, 2004). Like neural stem cells, these E-RoSH cell lines are highly proliferative and provide unlimited supply of cells for differentiation.…”